Loading…

Intracranial compliance in patients with COVID-19: a multicenter observational study

Patients with severe coronavirus disease-19 (COVID-19) may require the use of invasive mechanical ventilation (MV) for prolonged periods. Aggressive MV parameters have been associated with changes in intracranial pressure (ICP) in patients with acute intracranial disorders. Significant ICP elevation...

Full description

Saved in:
Bibliographic Details
Published in:Arquivos de neuro-psiquiatria 2024-09, Vol.82 (9), p.1-8
Main Authors: Silveira, Ana Flávia, Santos, Marcella Barreto, Collange, Nelci Zanon, Hayashi, Cintya Yukie, Vilela, Gustavo Henrique Frigieri, Almeida, Samantha Longhi Simões de, Andrade, João Brainer Clares de, Rojas, Salómon, Moraes, Fabiano Moulin de, Veiga, Viviane Cordeiro, Flato, Uri Adrian Prync, Russo, Thiago Luiz, Silva, Gisele Sampaio
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with severe coronavirus disease-19 (COVID-19) may require the use of invasive mechanical ventilation (MV) for prolonged periods. Aggressive MV parameters have been associated with changes in intracranial pressure (ICP) in patients with acute intracranial disorders. Significant ICP elevation could compromise intracranial compliance (ICC) and cerebrovascular hemodynamics (CVH). However, the effects of these parameters in individuals without neurological disorders have not yet been evaluated.  To evaluate ICC in patients on MV with COVID-19 infection compared to other diagnoses, to better characterize the effects of MV and COVID-19 upon ICC. We also compared between the ICC in patients with COVID-19 who did not require MV and healthy volunteers, to assess the isolated effect of COVID-19 upon ICC.  This was an exploratory, observational study with a convenience sample. The ICC was evaluated with a noninvasive ICP monitoring device. The P2/P1 ratio was calculated by dividing the amplitude of these two points, being defined as "abnormal" when P2 > P1. The statistical analysis was performed using a mixed linear model with random effects to compare the P2/P1 ratio in all four groups on the first monitoring day.  A convenience sample of 78 subjects (15 MV-COVID-19, 15 MV non-COVID-19, 24 non-MV-COVID-19, and 24 healthy participants) was prospectively enrolled. There was no difference in P2/P1 ratios between MV patients with and without COVID-19, nor between non-MV patients with COVID-19 and healthy volunteers. However, the P2/P1 ratio was higher in COVID-19 patients with MV use than in those without it.  This exploratory analysis suggests that COVID-19 does not impair ICC.
ISSN:0004-282X
1678-4227
1678-4227
DOI:10.1055/s-0044-1788669